CBT101 + Placebo
Phase 1Recruiting 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Neurologic Diseases, General
Conditions
Neurologic Diseases, General
Trial Timeline
Mar 14, 2025 → Sep 1, 2025
NCT ID
NCT07050316About CBT101 + Placebo
CBT101 + Placebo is a phase 1 stage product being developed by Brain Biotech for Neurologic Diseases, General. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07050316. Target conditions include Neurologic Diseases, General.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07050316 | Phase 1 | Recruiting |
Competing Products
1 competing product in Neurologic Diseases, General
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Stem Cell | Brain Biotech | Phase 1 | 25 |